Tags

Type your tag names separated by a space and hit enter

Long-term pharmacotherapy for obesity.
Obes Res. 2004 Dec; 12 Suppl:163S-6S.OR

Abstract

Obese patients unable to achieve significant weight loss with lifestyle changes alone may require drug therapy, and such therapy may be needed long term lest weight lost be regained. In the United States, only sibutramine and orlistat are available for the long-term treatment of obesity. Clinical trials have shown that both drugs can induce and maintain weight loss, even in patients with comorbid conditions such as hypertension or type 2 diabetes. Their use must be combined with behavior modification and a structured meal plan, however, for patients to reap the full benefits of such treatment.

Authors+Show Affiliations

Division of Geriatrics and Nutritional Sciences, Center for Human Nutrition, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8031, St. Louis, MO 63110, USA. sklein@im.wustl.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15687412

Citation

Klein, Samuel. "Long-term Pharmacotherapy for Obesity." Obesity Research, vol. 12 Suppl, 2004, 163S-6S.
Klein S. Long-term pharmacotherapy for obesity. Obes Res. 2004;12 Suppl:163S-6S.
Klein, S. (2004). Long-term pharmacotherapy for obesity. Obesity Research, 12 Suppl, 163S-6S.
Klein S. Long-term Pharmacotherapy for Obesity. Obes Res. 2004;12 Suppl:163S-6S. PubMed PMID: 15687412.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term pharmacotherapy for obesity. A1 - Klein,Samuel, PY - 2005/2/3/pubmed PY - 2005/4/1/medline PY - 2005/2/3/entrez SP - 163S EP - 6S JF - Obesity research JO - Obes Res VL - 12 Suppl N2 - Obese patients unable to achieve significant weight loss with lifestyle changes alone may require drug therapy, and such therapy may be needed long term lest weight lost be regained. In the United States, only sibutramine and orlistat are available for the long-term treatment of obesity. Clinical trials have shown that both drugs can induce and maintain weight loss, even in patients with comorbid conditions such as hypertension or type 2 diabetes. Their use must be combined with behavior modification and a structured meal plan, however, for patients to reap the full benefits of such treatment. SN - 1071-7323 UR - https://www.unboundmedicine.com/medline/citation/15687412/Long_term_pharmacotherapy_for_obesity_ L2 - https://doi.org/10.1038/oby.2004.283 DB - PRIME DP - Unbound Medicine ER -